Jan 14 2021 Read 344 Times
As part of the Government’s £213 million World Class Labs investment scheme bringing upgrades to research organisations across the UK, the University of Dundee has received two grants totaling more than £1 million in the areas of life sciences and arts and humanities.
The University’s MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) has been awarded £808,000 to purchase mass spectrometers and key computational resources to support research. Professor Dario Alessi, Director of the MRC-PPU, said, “We are immensely appreciative for this generous funding, especially during such challenging times. This has allowed us to purchase a state-of-the-art new mass spectrometer and other instruments to undertake biophysical analysis. This apparatus will help our investigators to better probe the biological mechanisms underlying diseases including cancer and Parkinson’s.”
Advertising Vehicles Welcomes New Team Member Jason Boyd
Jason Boyd Joins Leading Vehicle Graphics Company as a National Account Executive.
CINCINNATI, OH / ACCESSWIRE / January 14, 2021 / Advertising Vehicles recently welcomed Jason Boyd to its team as a National Account Executive. Based in Chicago, Boyd will focus on serving national fleet customers by helping them promote their brands and company vision through thoughtful and strategic fleet graphic solutions.
Jason Boyd, National Account Executive, Advertising Vehicles
With more than 20 years of experience in transportation, equipment engineering, and logistics design, Boyd has built relationships with some of the largest commercial and corporate fleets throughout the U.S. He is well-versed in guiding customers through their transportation journey by finding the right solutions to support and fulfill their goals.
Jan 14 2021 Read 266 Times
University of Birmingham (UK) scientists have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease, affecting over 70 million people worldwide, by lowering increased intraocular pressure (IOP) within the eye’s main fluid drainage site.,
OAG develops slowly over many years, leading to excessive matrix deposition (fibrosis), which in turn can lead to increased intraocular pressure (IOP), causing damage to the optic nerve and blindness.
The research has shown that that ILB can normalise matrix deposition inside the eye in a pre-clinical model used to mimic these aspects of human glaucoma, paving the way for new anti-fibrotic therapies to be developed for the disease.